Exicure, Inc. (XCUR) News
Filter XCUR News Items
XCUR News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
XCUR News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest XCUR News From Around the Web
Below are the latest news stories about EXICURE INC that investors may wish to consider to help them evaluate XCUR as an investment opportunity.
Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in BiotechCHICAGO, December 27, 2024--Exicure, Inc. Partners with GPCR Therapeutics Inc. to Fuel New Growth in Biotech |
CORRECTING and REPLACING Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board ChangesCHICAGO, December 21, 2024--Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes |
Exicure, Inc. Enters into Purchase Agreements for $1.3 Million and $8.7 Million Equity Financing and Reports Third Quarter 2024 Financial ResultsCHICAGO, November 14, 2024--Exicure, Inc. Enters into Purchase Agreements for $1.3 Million and $8.7 Million Equity Financing and Reports Third Quarter 2024 Financial Results |
Exicure, Inc. Receives Extension from Nasdaq Hearings PanelCHICAGO, September 18, 2024--Exicure, Inc. ("Exicure" or the "Company") (Nasdaq: XCUR), announced today that on September 17, 2024, the Company received notice that the Nasdaq Hearings Panel ("Panel") granted an extension to continue the Company’s listing subject to the Company evidencing compliance with all applicable criteria for continued listing on The Nasdaq Capital Market by November 14, 2024. The Company is diligently working to timely satisfy the terms of the Panel’s requests and to ensu |
Exicure, Inc. Announces Proposed Settlement of Securities Class Action LitigationCHICAGO, September 09, 2024--Exicure, Inc. Announces Proposed Settlement of Securities Class Action Litigation |
Exicure, Inc. Announces 1-for-5 Reverse Stock SplitCHICAGO, August 26, 2024--Exicure, Inc. (Nasdaq: XCUR, "the Company") today announced that it will effect a 1-for-5 reverse stock split of its outstanding shares of common stock (the "Reverse Stock Split"). The Company expects that the Reverse Stock Split will become effective at 5:00 pm on Tuesday, August 27, 2024, and its common stock will begin trading on a split-adjusted basis at the open of trading on Wednesday, August 28, 2024 under the new CUSIP number 30205M 309. Exicure’s common stock w |
Exicure, Inc. Announces Additional Adjournment of Special Meeting and Information for Reconvened Special MeetingCHICAGO, August 19, 2024--Exicure, Inc. Announces Additional Adjournment of Special Meeting and Information for Reconvened Special Meeting |
Exicure, Inc. Announces Adjournment of Special Meeting and Information for Reconvened Special MeetingCHICAGO, August 15, 2024--Exicure, Inc. Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting |
Exicure, Inc. Reports Second Quarter 2024 Financial ResultsCHICAGO, August 13, 2024--Exicure, Inc. Reports Second Quarter 2024 Financial Results |
Exicure, Inc. Recruits Head of Corporate Development and BioinformaticsCHICAGO, August 08, 2024--Exicure, Inc. Recruits Head of Corporate Development and Bioinformatics |